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ABSTRACT
Congenital anomalies are a significant burden on human health.
Understanding the developmental origins of such anomalies is key to
developing potential therapies. The Human Developmental Biology
Resource (HDBR), based in London and Newcastle, UK, was
established to provide embryonic and fetal material for a variety of
human studies ranging from single gene expression analysis to large-
scale genomic/transcriptomic studies. Increasingly, HDBRmaterial is
enabling the derivation of stem cell lines and contributing towards
developments in tissue engineering. Use of the HDBR and other fetal
tissue resources discussed here will contribute to the long-term aims
of understanding the causation and pathogenesis of congenital
anomalies, and developing new methods for their treatment and
prevention.
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Introduction
An important goal of developmental biology is to understand
human embryonic/fetal development and the causes of congenital
anomalies. A better understanding of the gene pathways that lead to
developmental anomalies will aid new medical approaches for
disease treatment and prevention. The causes of congenital
anomalies include a variety of genetic and environmental factors,
with the majority probably involving multifactorial aetiology. In
Europe the recorded prevalence of major congenital anomalies is
23.9 per 1000 pregnancies, of which 80% were live births and 20%
resulted in termination, fetal death or stillbirth (Dolk et al., 2010).
Children who survive with congenital anomalies frequently
experience long-term disability. For example, patients with
congenital heart defects (the commonest group of anomalies) may
develop severe disability in the first few days after birth (e.g.
transposition of the great vessels), often requiring early surgery. In
economic terms, the lifetime cost of caring for someone with a
severe birth defect, like spina bifida, is estimated at over $0.5
million (Yi et al., 2011). This represents a challenge not only for
individuals and families, but also for healthcare systems. In recent
decades it has become possible to prevent some congenital
anomalies. Two notable examples are vaccination of women
against rubella to reduce the number of newborn babies with
congenital rubella syndrome (Tookey and Peckham, 1999), and
supplementation with folic acid in early pregnancy to decrease the
prevalence of neural tube defects (Eichholzer et al., 2006).
Animal models are widely used to test hypotheses about the
development of the embryo and fetus. Over the last 10 years there
have been huge advances in the understanding of model organisms,
in terms of whole-genome sequencing, identifying gene regulatory
networks and determining developmental mechanisms. A striking
finding is that the majority of protein-coding genes are shared
between mouse and human (Yue et al., 2014). Therefore, the
differences between the species are unlikely to be due to gene
diversity but mainly to modifications in regulatory programmes
controlling where and when genes are expressed. The spatial and
temporal control of gene expression is therefore extremely
important and might help to explain what makes us human.
As well as similarities, there are many established differences
between the development of humans and model organisms such as
the mouse. Most notably, during evolution the brain has changed
in size and shape. Differences are particularly evident in the
development of the human cerebral cortex (Bae et al., 2015), with
huge increases in the number of cells and in the complexity of cell
types. The cortex of the human brain also undergoes a process of
folding known as gyrification, which increases the number of
cortical neurons. This gyrification is thought to correlate with
increased cognitive abilities (Gautam et al., 2015). The mouse brain
does not undergo gyrification.
As another example, the eyes of humans are also more complex:
they contain three types of cone cells as opposed to only two in
mice; while the macula – a highly pigmented area at the back of the
human retina – is absent in mice. A number of genes whose
mutation is associated with human congenital syndromes, such as
KAL1 (ANOS1) (Cadman et al., 2007) and SHOX (Blaschke and
Rappold, 2006), are not found in the mouse genome. Thus, although
model organisms have proved hugely valuable in understanding
developmental processes, there is also a need to study human tissue
directly.
Here, we present an overview of the resources available to the
research community for analysing human development, with a
particular focus on the Human Developmental Biology Resource
(HDBR). Resources such as tissue banks, bioinformatics portals and
archive collections provide researchers with crucial information and
material for the analysis of human development and associated
congenital abnormalities.
Research tissue banks
Several research tissue banks have been created in the UK and
elsewhere to enable researchers to gain access to human embryonic
and fetal samples. These banks collect tissue in a systematic fashion
and conform to the highest ethical standards and research
governance.
The Human Developmental Biology Resource (HDBR)
The HDBR (www.hdbr.org; with whom the authors are associated)
was established in 1999 and is funded by the Medical Research
Council and Wellcome Trust. It has National Research Ethics
Service approval and is licensed by the UKHuman Tissue Authority
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(https://www.hta.gov.uk/). The collection of material from elective
terminations of pregnancy currently comprises over 4000 specimens
aged between 3 and 20 post-conception weeks (pcw). The resource
continues to collect material, with 400 new specimens added each year.
All specimens are karyotyped, with 4% having chromosomal
abnormalities (most commonly trisomy 21 and monosomy X) and
9% displaying some form of phenotypic abnormality.
Various types of sample are available from the HDBR (Fig. 1).
The majority of tissue provided by the resource is from
chromosomally normal samples but material can also be provided
from specimens with chromosomal abnormalities. Fresh tissue from
specific organs and developmental ages can be used in a range of
scientific procedures, such as fluorescence-activated cell sorting of
live cells to purify specific human fetal cell populations in order to
derive primary cell lines or stem cells. Frozen tissue can be used for
the production of mRNA, genomic DNA or protein. These samples
are being used in large-scale transcriptome analyses to compare
human and animal models and across specific tissues, sexes and
between normal and karyotypically abnormal samples.
The HDBR also provides a gene expression service using RNA
in situ hybridisation or protein immunohistochemistry. Sectioned
embryonic or fetal tissue is used to identify the temporal and
spatial expression of specific genes or proteins. Gene expression data
from this service, as well as data generated by external projects, are
digitally imaged and made accessible via an open access database
(www.hudsen.org). Some stained sections are also available at high
resolution (http://nbb-slidepath.ncl.ac.uk/dih; username and password
available on request).
Material can be provided to researchers in the UK without the
need for project ethics review, as well as to international groups with
relevant ethical review body approvals. Over 10,000 slides and
tissue samples have been distributed to registered users in the last
5 years, and ∼100 projects are registered per year. The majority of
projects are based in the UK, but a growing number of users are in
the USA (17%), mainland Europe (11%) and other locations
worldwide. Distribution of human embryonic and fetal tissue is
prioritised to projects that investigate congenital disorders. Of
particular interest are studies that aim to understand the function of
genes important for early development, genes linked to human-
specific functions (e.g. cognitive function and language) and genes
associated with significant anatomical or functional differences
between mice and humans.
A wide variety of studies have been carried out using HDBR
materials (Fig. 2). These range from investigation of single genes
underlying genetic disorders (Tischfield et al., 2010; Thomas et al.,
2014) to high-throughput studies of transcriptomes (Kang et al.,
2011) and regulatory sequences (Necsulea et al., 2014). Advances
in high-throughput sequencing technologies have opened the door
to large-scale cross-species comparisons that are highlighting
differences in transcript sequence, alternative splicing, expression
level and regulation between humans and model organisms (Cotney
et al., 2013; Bae et al., 2014). Some studies, such as the
investigation of tail bud development in chick and human
(Olivera-Martinez et al., 2012), dissect key processes of early
development. Organ-specific tissues have been used for the
derivation of primary cell lines and stem cells (U et al., 2014).
Other tissue banks
A number of other groups, in the UK and USA, have set up
collections of human fetal material. These are normally organised
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Fig. 1. Examples of resources available
from the HDBR. (A) Images of embryos at
(from left to right) CS12 [∼26 days post
conception (dpc)], CS16 (∼37 dpc) and CS19
(∼47 dpc). (B) ACS17 (∼41 dpc) embryo with
trisomy 21. (C) CS12-CS21 series of 3D
models, generated using optical projection
tomography (OPT) from embryos in the
HDBR collection, displayed at their relative
sizes. Movies and images of the models can
be viewed or the full models requested via the
HuDSeN website (www.hudsen.org). (D) The
HDBR provides access to curated gene
expression data. The upper image shows a
section through a CS17 embryo stained with
anti-GAP43 antibody (brown); the lower image
is of the corresponding section in the CS17
OPT model onto which the GAP43 expression
data have been mapped (red, strong
expression; yellow, moderate expression).
Expression data were mapped from
experimental sections to digital sections using
MAPaint software (http://www.emouseatlas.
org/emap/home.html). (E) 3D expression
domain of GAP43 expression in the head and
part of the body built up by mapping data from
sections as shown in D. Experimental and
mapped data are uploaded to a spatial
database (www.hudsen.org). (F) Word cloud
representation of the expression data available
in the HuDSeN human gene expression spatial
database (www.hudsen.org). The word cloud
represents the number of entries for each gene
and there are currently data from 128 genes.
Scale bars: 1 mm.
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around defined scientific projects and the samples are not usually
available to the wider scientific community. However, there are
exceptions where banks have been established to provide material
for use in research. For example, the South Wales Initiative for Fetal
Tissue (http://www.biobankswales.org.uk/swift-research-tissue-
bank/) provides clinical grade fetal tissue (5 and 12 pcw)
primarily for human therapeutics, and the University of Maryland
Brain and Tissue Bank in the USA (http://medschool.umaryland.
edu/btbank/catalog.asp) can provide access to both adult and fetal
tissue.
Bioinformatics portals
A number of sites provide valuable information on human
development for researchers. For example, the BrainSpan project
(www.brainspan.org) has generated transcriptome data and gene
expression data from multiple regions of the embryonic, fetal and
adult brain. The UNSW Embryology portal is an education and
research website that has links to many collections of human
embryonic and fetal specimens (https://embryology.med.unsw.edu.
au/embryology/index.php/).
In the UK a consortium of UKCRC funders has established
The National Tissue Directory and Coordination Centre (www.
biobankinguk.org). This directory will enable researchers to find
human biobanks within the UK and gain access to their collections
through one system. These and other bioinformatics databases are
essential resources for researchers, particularly those whose access
to primary tissue is limited.
Archive resources
The Carnegie collection (www.ehd.org/virtual-human-embryo/)
Seven thousand human embryos are stored in the Carnegie
collection at the National Museum of Health and Medicine,
Washington, D.C. This material was used to develop the
comprehensive Carnegie staging system based on internal as well
as external features. Carnegie staging (CS1-23) is now employed
universally in human embryo research. Individual embryos
throughout the embryonic period have been sectioned and, in an
attempt to make the collection more accessible for research and
teaching, digital images from a subset of these have been acquired.
The images are labelled with standard anatomy terms to help with
interpretation, or used to generate 3D models and 252 movies.
The Kyoto collection (http://bird.cac.med.kyoto-u.ac.jp/index_e.html)
This is the largest human embryo collection in the world, with over
44,000 specimens between CS7 and CS23.Maternal epidemiological
data and detailed clinical information on the pregnancies were
collected for each specimen. Five hundred normal and 500 abnormal
embryos have been serially sectioned, and a further 1300 staged
human embryos have been digitally imaged by magnetic resonance
(MR) microscopy and 3D reconstructions produced.
Conclusions
The landscape for developmental biology and clinical research has
changed within the last few years, with more emphasis being placed
on large-scale sequencing projects such as the Genotype-Tissue
Expression Project (GTEx Consortium, 2013), Geuvadis
(Lappalainen et al., 2013) and the UK 100,000 Genomes Project
(Siva, 2015). These projects and numerous others aim to map
variations in gene expression in thousands of individual patients and
correlate this with disease phenotypes and bioinformatics
information on sites such as the Encyclopedia of DNA Elements
(ENCODE; https://www.encodeproject.org/; Kellis et al., 2014).
Other studies are using novel algorithms to interrogate the
sequencing data to investigate gene networks (Liu et al., 2014).
These projects are now identifying candidate genes that could play a
role in a range of human diseases and syndromes.
The next step in this gene discovery pipeline will be to test
candidate genes in model organisms and human tissue. This
analysis needs to be performed at the cellular level to determine
whether the genes are expressed in tissues and cell types relevant
to the disease under study. The HDBR is ideally placed to assist
researchers wishing to investigate genes thought to be responsible
for congenital abnormalities. In addition, some groups are using
material provided by the HDBR to study epigenetic regulation
and in functional studies. Other projects include the derivation of
stem cells and scaffolds for tissue engineering projects. It is
likely in the coming years that the HDBR will not only support
projects wishing to understand key developmental processes but
Cell
lines
Functional
assays
Gene expression service
Researcher generated
A  In situ hybridisation studies B  Immunohistochemistry studies
C  Cell or tissue studies D  Individual gene
     expression studies
E  Global gene expression studies
Fig. 2. HDBRmaterial has been used
in many different types of studies.
Examples are shown of the types of
study carried out using HDBR material.
(A,B) Examples from the gene
expression service. HDBR staff
perform gene expression analysis on
sectioned tissue by in situ hybridisation
(A) or immunohistochemistry (B) on
behalf of researchers. (C-E) The types
of studies that researchers carry out in
their own laboratories with material
provided by HDBR: to produce cell lines
or perform functional analysis (C); gene
expression studies in paraffin fixed
sections (D); and transcriptomics
studies in cells or tissues (E).
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will also increasingly provide resources to underpin translational
research.
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